title: Promyelocytic Blastic Crisis in Chronic Myeloid Leukemia During Imatinib Treatment.
authors: Buenos Aires University School of Medicine, Hospital Italiano de Buenos Aires, Department of Internal Medicine, Buenos Aires, Argentina E-mail: federico.angriman@hospitalitaliano.org.ar Phone: +54-11-49590200 Ext: 4419.
authors: Federico
authors: F
authors: Angriman
authors: Maria Nelly
authors: MN
authors: Gutierrez Acevedo
authors: Maria Sol
authors: MS
authors: Rossi
authors: Alberto Daniel
authors: AD
authors: Gimenez Conca
authors: Victoria
authors: V
authors: Otero
authors: Jorge Alberto
authors: JA
authors: Arbelbide
authors: Hernán
authors: H
authors: Michelángelo
mesh_terms: D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001752:Blast Crisis / Q000097:blood*; D001853:Bone Marrow / Q000473:pathology*; D005260:Female; D042381:Granulocyte Precursor Cells / Q000473:pathology*; D006801:Humans; D000068877:Imatinib Mesylate / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D000068877:Imatinib Mesylate